Abstract
Neuropathology and Applied NeurobiologyVolume 45, Issue 2 p. 183-186 Scientific Correspondence APOE ε4 is also required in TREM2 R47H variant carriers for Alzheimer's disease to develop C. E. Murray, C. E. Murray Queen Square Brain Bank for Neurological Disorders, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UKSearch for more papers by this authorA. King, A. King orcid.org/0000-0002-7974-2589 Department of Clinical Neuropathology, Kings College Hospital, London, UK London Neurodegenerative Diseases Brain Bank, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UKSearch for more papers by this authorC. Troakes, C. Troakes London Neurodegenerative Diseases Brain Bank, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UKSearch for more papers by this authorA. Hodges, A. Hodges Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UKSearch for more papers by this authorT. Lashley, T. Lashley orcid.org/0000-0001-7389-0348 Queen Square Brain Bank for Neurological Disorders, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UKSearch for more papers by this author C. E. Murray, C. E. Murray Queen Square Brain Bank for Neurological Disorders, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UKSearch for more papers by this authorA. King, A. King orcid.org/0000-0002-7974-2589 Department of Clinical Neuropathology, Kings College Hospital, London, UK London Neurodegenerative Diseases Brain Bank, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UKSearch for more papers by this authorC. Troakes, C. Troakes London Neurodegenerative Diseases Brain Bank, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, UK Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, UKSearch for more papers by this authorA. Hodges, A. Hodges Maurice Wohl Clinical Neuroscience Institute, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UKSearch for more papers by this authorT. Lashley, T. Lashley orcid.org/0000-0001-7389-0348 Queen Square Brain Bank for Neurological Disorders, Department of Molecular Neuroscience, UCL Institute of Neurology, London, UKSearch for more papers by this author First published: 07 February 2018 https://doi.org/10.1111/nan.12474Citations: 10Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume45, Issue2February 2019Pages 183-186 RelatedInformation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
